BIRC5 and colorectal carcinoma: It is noteworthy that in all human CRC cell lines examined, a blockade of proteasomal degradation failed to nullify Obatoclax-induced survivin downregulation, thus excluding the involvement of survivin protein destabilization in the inhibitory effect of Obatoclax on survivin expression (Figure 2D).